APO Research
Talk to an analyst

APO RESEARCH · REPORT

G-Protein Coupled Receptor (GPCR) Targeting

G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.

Selected research

Market Outlook & Growth Opportunities

Global G-Protein Coupled Receptor (GPCR) Targeting Market Outlook and Growth Opportunities 2026

9 January 2026194 pages

Choose your research edition.

Industry ResearchG-Protein Coupled Receptor (GPCR) Targeting Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal G-Protein Coupled Receptor (GPCR) Targeting Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal G-Protein Coupled Receptor (GPCR) Targeting Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal G-Protein Coupled Receptor (GPCR) Targeting Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal G-Protein Coupled Receptor (GPCR) Targeting Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.

Global G-Protein Coupled Receptor (GPCR) Targeting key players include Thermo Fisher Scientific, PerkinElmer, Merck, BD Biosciences, Molecular Devices etc. Global top five manufacturers hold a share over 40%.

North America is the largest market, with a share over 40%, followed by Japan and Europe, both have a share over 35% percent.

Read the full market overview

In terms of product, GPCR Consumables is the largest segment, with a share over 60%. And in terms of application, the largest application is Oncology followed by Cardiovascular System.

This report provides an overview of the global G-Protein Coupled Receptor (GPCR) Targeting market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of G-Protein Coupled Receptor (GPCR) Targeting and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents G-Protein Coupled Receptor (GPCR) Targeting sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the G-Protein Coupled Receptor (GPCR) Targeting market size, projected growth trends, production technologies, key applications, and end-use industries.

G-Protein Coupled Receptor (GPCR) Targeting Segment by Company

Thermo Fisher Scientific

PerkinElmer

Merck

BD Biosciences

Molecular Devices

Promega

Qiagen

Abcam

Corning

Cisbio

Discoverx

Enzo Life Sciences

G-Protein Coupled Receptor (GPCR) Targeting Segment by Type

GPCR Consumables

GPCR Equipment

G-Protein Coupled Receptor (GPCR) Targeting Segment by Application

Oncology

Cardiovascular System

Central Nervous System

Other

G-Protein Coupled Receptor (GPCR) Targeting Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global G-Protein Coupled Receptor (GPCR) Targeting status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions G-Protein Coupled Receptor (GPCR) Targeting market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify G-Protein Coupled Receptor (GPCR) Targeting significant trends, drivers, influence factors in global and regions.

6. To analyze G-Protein Coupled Receptor (GPCR) Targeting competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global G-Protein Coupled Receptor (GPCR) Targeting market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of G-Protein Coupled Receptor (GPCR) Targeting and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of G-Protein Coupled Receptor (GPCR) Targeting.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the G-Protein Coupled Receptor (GPCR) Targeting market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global G-Protein Coupled Receptor (GPCR) Targeting industry.

Chapter 3: Detailed analysis of G-Protein Coupled Receptor (GPCR) Targeting manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of G-Protein Coupled Receptor (GPCR) Targeting in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of G-Protein Coupled Receptor (GPCR) Targeting in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. G-Protein Coupled Receptor (GPCR) Targeting Industry Trends Table 2. G-Protein Coupled Receptor (GPCR) Targeting Industry Drivers Table 3. G-Protein Coupled Receptor (GPCR) Targeting Industry Opportunities and Challenges Table 4. G-Protein Coupled Receptor (GPCR) Targeting Industry Restraints Table 5. Global G-Protein Coupled Receptor (GPCR) Targeting Revenue by Company (US$ Million) & (2021-2026) Table 6. Global G-Protein Coupled Receptor (GPCR) Targeting Revenue Share by Company (2021-2026) Table 7. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Company (K MT) & (2021-2026) Table 8. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share by Company (2021-2026) Table 9. Global G-Protein Coupled Receptor (GPCR) Targeting Average Price (USD/MT) of Company (2021-2026) Table 10. Global G-Protein Coupled Receptor (GPCR) Targeting Company Ranking, (2024-2026) & (USD Million) Table 11. Global G-Protein Coupled Receptor (GPCR) Targeting Key Company Manufacturing Base & Headquarters Table 12. Global G-Protein Coupled Receptor (GPCR) Targeting Company, Product Type & Application Table 13. Global G-Protein Coupled Receptor (GPCR) Targeting Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global G-Protein Coupled Receptor (GPCR) Targeting by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of GPCR Consumables Table 18. Significant Companies of GPCR Equipment Table 19. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Type 2021 VS 2025 VS 2032 (K MT) Table 20. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Type (2021-2026) & (K MT) Table 21. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Type (2027-2032) & (K MT) Table 22. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share by Type (2021-2026) Table 23. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share by Type (2027-2032) Table 24. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type (2021-2026) Table 28. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Oncology Table 30. Significant Companies of Cardiovascular System Table 31. Significant Companies of Central Nervous System Table 32. Significant Companies of Other Table 33. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Application 2021 VS 2025 VS 2032 (K MT) Table 34. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Application (2021-2026) & (K MT) Table 35. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Application (2027-2032) & (K MT) Table 36. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share by Application (2021-2026) Table 37. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share by Application (2027-2032) Table 38. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application (2021-2026) Table 42. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application (2027-2032) Table 43. Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Region: 2021 VS 2025 VS 2032 (K MT) Table 44. Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Region (2021-2026) & (K MT) Table 45. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Market Share by Region (2021-2026) Table 46. Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Region (2027-2032) & (K MT) Table 47. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Market Share by Region (2027-2032) Table 48. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Region (2021-2026) Table 51. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Region (2027-2032) Table 53. Global G-Protein Coupled Receptor (GPCR) Targeting Market Average Price (USD/MT) by Region (2021-2026) Table 54. Global G-Protein Coupled Receptor (GPCR) Targeting Market Average Price (USD/MT) by Region (2027-2032) Table 55. Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Country: 2021 VS 2025 VS 2032 (K MT) Table 56. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Country (2021-2026) & (K MT) Table 58. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Market Share by Country (2021-2026) Table 59. Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Country (2027-2032) & (K MT) Table 60. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Market Share by Country (2027-2032) Table 61. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Market Share by Country (2021-2026) Table 63. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Market Share by Country (2027-2032) Table 65. Thermo Fisher Scientific Company Information Table 66. Thermo Fisher Scientific Business Overview Table 67. Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 68. Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 69. Thermo Fisher Scientific Recent Development Table 70. PerkinElmer Company Information Table 71. PerkinElmer Business Overview Table 72. PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 73. PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 74. PerkinElmer Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 78. Merck G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 79. Merck Recent Development Table 80. BD Biosciences Company Information Table 81. BD Biosciences Business Overview Table 82. BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 83. BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 84. BD Biosciences Recent Development Table 85. Molecular Devices Company Information Table 86. Molecular Devices Business Overview Table 87. Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 88. Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 89. Molecular Devices Recent Development Table 90. Promega Company Information Table 91. Promega Business Overview Table 92. Promega G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 93. Promega G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 94. Promega Recent Development Table 95. Qiagen Company Information Table 96. Qiagen Business Overview Table 97. Qiagen G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 98. Qiagen G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 99. Qiagen Recent Development Table 100. Abcam Company Information Table 101. Abcam Business Overview Table 102. Abcam G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 103. Abcam G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 104. Abcam Recent Development Table 105. Corning Company Information Table 106. Corning Business Overview Table 107. Corning G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 108. Corning G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 109. Corning Recent Development Table 110. Cisbio Company Information Table 111. Cisbio Business Overview Table 112. Cisbio G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 113. Cisbio G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 114. Cisbio Recent Development Table 115. Discoverx Company Information Table 116. Discoverx Business Overview Table 117. Discoverx G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 118. Discoverx G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 119. Discoverx Recent Development Table 120. Enzo Life Sciences Company Information Table 121. Enzo Life Sciences Business Overview Table 122. Enzo Life Sciences G-Protein Coupled Receptor (GPCR) Targeting Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 123. Enzo Life Sciences G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio Table 124. Enzo Life Sciences Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. G-Protein Coupled Receptor (GPCR) Targeting Distributors List Table 128. G-Protein Coupled Receptor (GPCR) Targeting Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. G-Protein Coupled Receptor (GPCR) Targeting Product Image Figure 2. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032) & (US$ Million) Figure 4. Global G-Protein Coupled Receptor (GPCR) Targeting Sales (2021-2032) & (K MT) Figure 5. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global G-Protein Coupled Receptor (GPCR) Targeting Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. GPCR Consumables Image Figure 10. GPCR Equipment Image Figure 11. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Type (2021 VS 2025 VS 2032) & (K MT) Figure 12. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share by Type (2021-2032) Figure 14. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type (2021-2032) Figure 17. Oncology Image Figure 18. Cardiovascular System Image Figure 19. Central Nervous System Image Figure 20. Other Image Figure 21. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Application (2021 VS 2025 VS 2032) & (K MT) Figure 22. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share by Application (2021-2032) Figure 24. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application (2021-2032) Figure 27. Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Region: 2021 VS 2025 VS 2032 (K MT) Figure 28. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032) & (US$ Million) Figure 32. North America G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032) & (US$ Million) Figure 34. Europe G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032) & (US$ Million) Figure 38. South America G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. G-Protein Coupled Receptor (GPCR) Targeting Value Chain Figure 126. Manufacturing Cost Structure Figure 127. G-Protein Coupled Receptor (GPCR) Targeting Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • GPCR Consumables
  • GPCR Equipment
Applications
  • Oncology
  • Cardiovascular System
  • Central Nervous System
  • Other
Companies covered
  • Thermo Fisher Scientific
  • PerkinElmer
  • Merck
  • BD Biosciences
  • Molecular Devices
  • Promega
  • Qiagen
  • Abcam
  • Corning
  • Cisbio
  • Discoverx
  • Enzo Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032)
  4. 1.2.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume (2021-2032)
  5. 1.2.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 G-Protein Coupled Receptor (GPCR) Targeting Market Dynamics
  1. 2.1 G-Protein Coupled Receptor (GPCR) Targeting Industry Trends
  2. 2.2 G-Protein Coupled Receptor (GPCR) Targeting Industry Drivers
  3. 2.3 G-Protein Coupled Receptor (GPCR) Targeting Industry Opportunities and Challenges
  4. 2.4 G-Protein Coupled Receptor (GPCR) Targeting Industry Restraints
3 G-Protein Coupled Receptor (GPCR) Targeting Market by Company
  1. 3.1 Global G-Protein Coupled Receptor (GPCR) Targeting Company Revenue Ranking in 2025
  2. 3.2 Global G-Protein Coupled Receptor (GPCR) Targeting Revenue by Company (2021-2026)
  3. 3.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Company (2021-2026)
  4. 3.4 Global G-Protein Coupled Receptor (GPCR) Targeting Average Price by Company (2021-2026)
  5. 3.5 Global G-Protein Coupled Receptor (GPCR) Targeting Company Ranking (2024-2026)
  6. 3.6 Global G-Protein Coupled Receptor (GPCR) Targeting Company Manufacturing Base and Headquarters
  7. 3.7 Global G-Protein Coupled Receptor (GPCR) Targeting Company Product Type and Application
  8. 3.8 Global G-Protein Coupled Receptor (GPCR) Targeting Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global G-Protein Coupled Receptor (GPCR) Targeting Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 G-Protein Coupled Receptor (GPCR) Targeting Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 G-Protein Coupled Receptor (GPCR) Targeting Market by Type
  1. 4.1 G-Protein Coupled Receptor (GPCR) Targeting Type Introduction
  2. 4.1.1 GPCR Consumables
  3. 4.1.2 GPCR Equipment
  4. 4.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Type
  5. 4.2.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Type (2021-2032)
  7. 4.2.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share by Type (2021-2032)
  8. 4.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Type
  9. 4.3.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Type (2021-2032)
  11. 4.3.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type (2021-2032)
5 G-Protein Coupled Receptor (GPCR) Targeting Market by Application
  1. 5.1 G-Protein Coupled Receptor (GPCR) Targeting Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiovascular System
  4. 5.1.3 Central Nervous System
  5. 5.1.4 Other
  6. 5.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Application
  7. 5.2.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume by Application (2021-2032)
  9. 5.2.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Volume Share by Application (2021-2032)
  10. 5.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Application
  11. 5.3.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Application (2021-2032)
  13. 5.3.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application (2021-2032)
6 G-Protein Coupled Receptor (GPCR) Targeting Regional Sales and Value Analysis
  1. 6.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Region (2021-2032)
  3. 6.2.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Region: 2021-2026
  4. 6.2.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Region (2027-2032)
  5. 6.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Region (2021-2032)
  7. 6.4.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Region: 2021-2026
  8. 6.4.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Region (2027-2032)
  9. 6.5 Global G-Protein Coupled Receptor (GPCR) Targeting Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032)
  12. 6.6.2 North America G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032)
  15. 6.7.2 Europe G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032)
  21. 6.9.2 South America G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Country, 2025 VS 2032
7 G-Protein Coupled Receptor (GPCR) Targeting Country-level Sales and Value Analysis
  1. 7.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Country (2021-2032)
  4. 7.3.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Country (2021-2026)
  5. 7.3.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales by Country (2027-2032)
  6. 7.4 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Country (2021-2032)
  7. 7.4.1 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Country (2021-2026)
  8. 7.4.2 Global G-Protein Coupled Receptor (GPCR) Targeting Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt G-Protein Coupled Receptor (GPCR) Targeting Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt G-Protein Coupled Receptor (GPCR) Targeting Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 PerkinElmer
  8. 8.2.1 PerkinElmer Company Information
  9. 8.2.2 PerkinElmer Business Overview
  10. 8.2.3 PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  12. 8.2.5 PerkinElmer Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 BD Biosciences
  20. 8.4.1 BD Biosciences Company Information
  21. 8.4.2 BD Biosciences Business Overview
  22. 8.4.3 BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  24. 8.4.5 BD Biosciences Recent Developments
  25. 8.5 Molecular Devices
  26. 8.5.1 Molecular Devices Company Information
  27. 8.5.2 Molecular Devices Business Overview
  28. 8.5.3 Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  30. 8.5.5 Molecular Devices Recent Developments
  31. 8.6 Promega
  32. 8.6.1 Promega Company Information
  33. 8.6.2 Promega Business Overview
  34. 8.6.3 Promega G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Promega G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  36. 8.6.5 Promega Recent Developments
  37. 8.7 Qiagen
  38. 8.7.1 Qiagen Company Information
  39. 8.7.2 Qiagen Business Overview
  40. 8.7.3 Qiagen G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Qiagen G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  42. 8.7.5 Qiagen Recent Developments
  43. 8.8 Abcam
  44. 8.8.1 Abcam Company Information
  45. 8.8.2 Abcam Business Overview
  46. 8.8.3 Abcam G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Abcam G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  48. 8.8.5 Abcam Recent Developments
  49. 8.9 Corning
  50. 8.9.1 Corning Company Information
  51. 8.9.2 Corning Business Overview
  52. 8.9.3 Corning G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Corning G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  54. 8.9.5 Corning Recent Developments
  55. 8.10 Cisbio
  56. 8.10.1 Cisbio Company Information
  57. 8.10.2 Cisbio Business Overview
  58. 8.10.3 Cisbio G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cisbio G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  60. 8.10.5 Cisbio Recent Developments
  61. 8.11 Discoverx
  62. 8.11.1 Discoverx Company Information
  63. 8.11.2 Discoverx Business Overview
  64. 8.11.3 Discoverx G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Discoverx G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  66. 8.11.5 Discoverx Recent Developments
  67. 8.12 Enzo Life Sciences
  68. 8.12.1 Enzo Life Sciences Company Information
  69. 8.12.2 Enzo Life Sciences Business Overview
  70. 8.12.3 Enzo Life Sciences G-Protein Coupled Receptor (GPCR) Targeting Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Enzo Life Sciences G-Protein Coupled Receptor (GPCR) Targeting Product Portfolio
  72. 8.12.5 Enzo Life Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 G-Protein Coupled Receptor (GPCR) Targeting Value Chain Analysis
  2. 9.1.1 G-Protein Coupled Receptor (GPCR) Targeting Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 G-Protein Coupled Receptor (GPCR) Targeting Sales Mode & Process
  6. 9.2 G-Protein Coupled Receptor (GPCR) Targeting Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 G-Protein Coupled Receptor (GPCR) Targeting Distributors
  9. 9.2.3 G-Protein Coupled Receptor (GPCR) Targeting Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst